+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Usher Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Usher Syndrome - Pipeline Insight, 2024

  • Drug Pipelines
  • August 2024
  • 60 Pages
  • Global
From
Graft versus host disease (GvHD) - Pipeline Insight, 2024 - Product Thumbnail Image

Graft versus host disease (GvHD) - Pipeline Insight, 2024

  • Drug Pipelines
  • August 2024
  • 180 Pages
  • Global
From
Etanercept - Biosimilar Insight, 2024 - Product Thumbnail Image

Etanercept - Biosimilar Insight, 2024

  • Report
  • August 2024
  • 60 Pages
  • Global
From
Psoriatic Arthritis - Pipeline Insight, 2024 - Product Thumbnail Image

Psoriatic Arthritis - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 80 Pages
  • Global
From
Open-Angle Glaucoma - Pipeline Insight, 2024 - Product Thumbnail Image

Open-Angle Glaucoma - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 80 Pages
  • Global
From
Acne Vulgaris- Pipeline Insight, 2024 - Product Thumbnail Image

Acne Vulgaris- Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 80 Pages
  • Global
From
Post-Transplant Lymphoproliferative Disorder - Pipeline Insight, 2024 - Product Thumbnail Image

Post-Transplant Lymphoproliferative Disorder - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 60 Pages
  • Global
From
Lichen Planus- Pipeline Insight, 2024 - Product Thumbnail Image

Lichen Planus- Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 60 Pages
  • Global
From
Opioid Overdose - Pipeline Insight, 2024 - Product Thumbnail Image

Opioid Overdose - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 60 Pages
  • Global
From
Vascular Dementia - Pipeline Insight, 2024 - Product Thumbnail Image

Vascular Dementia - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 60 Pages
  • Global
From
Scleroderma - Pipeline Insight, 2024 - Product Thumbnail Image

Scleroderma - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 240 Pages
  • Global
From
Bronchiolitis Obliterans Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Bronchiolitis Obliterans Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 60 Pages
  • Global
From
Nontuberculous Mycobacterial Infections - Pipeline Insight, 2024 - Product Thumbnail Image

Nontuberculous Mycobacterial Infections - Pipeline Insight, 2024

  • Drug Pipelines
  • August 2024
  • 60 Pages
  • Global
From
22q11.2 Deletion Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

22q11.2 Deletion Syndrome - Pipeline Insight, 2024

  • Drug Pipelines
  • August 2024
  • 60 Pages
  • Global
From
Pheochromocytoma- Pipeline Insight, 2024 - Product Thumbnail Image

Pheochromocytoma- Pipeline Insight, 2024

  • Drug Pipelines
  • August 2024
  • 60 Pages
  • Global
From
Sepsis- Pipeline Insight, 2024 - Product Thumbnail Image

Sepsis- Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 80 Pages
  • Global
From
Leigh Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Leigh Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 60 Pages
  • Global
From
Atrial Fibrillation - Pipeline Insight, 2024 - Product Thumbnail Image

Atrial Fibrillation - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 60 Pages
  • Global
From
Dravet Syndrome- Pipeline Insight, 2024 - Product Thumbnail Image

Dravet Syndrome- Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 60 Pages
  • Global
From
Rett Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Rett Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more